|Bid||135.14 x 900|
|Ask||135.18 x 1000|
|Day's Range||134.82 - 136.41|
|52 Week Range||80.24 - 140.36|
|Beta (3Y Monthly)||0.70|
|PE Ratio (TTM)||145.53|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||146.17|
President & CEO of Haemonetics Corp (30-Year Financial, Insider Trades) Christopher Simon, (insider trades) sold 50,869 shares of HAE on 08/19/2019 at an average price of $137.43 a share. Continue reading...
Attractive stocks have exceptional fundamentals. In the case of Haemonetics Corporation (NYSE:HAE), there's is a...
Haemonetics (HAE) provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals, notes Leo Fasciocco, breakout stock specialist and editor of Ticker Tape Digest.
Haemonetics (HAE) delivered earnings and revenue surprises of 28.57% and -0.01%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Financial release accessible online BRAINTREE, Mass. , Aug. 6, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter of fiscal 2020, which ended ...
How far off is Haemonetics Corporation (NYSE:HAE) from its intrinsic value? Using the most recent financial data...
BRAINTREE, Mass. , July 22, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced changes to its financial reporting segments and business units. The updated reporting segments and business ...
Intuitive Surgical's (ISRG) acquisition of Scholly Fiberoptic's robotic endoscope business to likely boost the acquirer's da Vinci Surgical system.
Haemonetics Corporation (HAE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Varian (VAR) expects to enhance cancer care with the new collaboration with IAEA, which is likely to drive Varian's core Oncology business.
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.
With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.